Cerus Corp
NASDAQ:CERS
Cerus Corp
NASDAQ:CERS
Price:
1.72 USD
2.99%
Market Closed
Updated:
May 2, 2024
Section:
Relative Value
The Relative Value of one
CERS
stock under the Base Case scenario is
3.93
USD.
Compared to the current market price of 1.72 USD,
Cerus Corp
is
Undervalued by 56%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CERS
Relative Value
Base Case
3.93
USD
Undervaluation 56%
Valuation Multiples
Multiples Across Competitors
CERS Competitors Multiples
Cerus Corp Competitors
Cerus Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Cerus Corp
NASDAQ:CERS
|
311.7m USD | 1.7 | -8.3 | -12.9 | -11.6 | |
| JP |
|
Hoya Corp
TSE:7741
|
6.5T JPY | 8.6 | 38.7 | 23.5 | 29 | |
| CH |
|
Alcon AG
SIX:ALC
|
35.1B CHF | 4 | 39.3 | 17.5 | 35.7 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
188B DKK | 7.5 | 38.6 | 25.4 | 29.5 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
21.4B USD | 5.5 | 46.3 | 25.4 | 30.9 | |
| US |
|
Cooper Companies Inc
NYSE:COO
|
17.8B USD | 4.9 | 61.3 | 22.4 | 38.1 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
14.4T KRW | 336.6 | -76.4 | -124.5 | -114.9 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
55.6B CNY | 14.1 | 33.6 | 29.2 | 29.2 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5B GBP | 2.9 | 48.3 | 46.7 | 50.8 | |
| US |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
6.3B USD | 1.6 | -47.4 | 12.1 | 26.1 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.5B CHF | 8.8 | 62 | 29.5 | 57.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
